Loading clinical trials...
Loading clinical trials...
Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19: A Randomized, Controlled Study CRI-CP (Coronavirus Investigation - Convalescent Plasma)
Conditions
Interventions
SARS-CoV-2 convalescent plasma treatment
Standard care
Locations
1
Colombia
Fundación Santa Fe de Bogotá
Bogotá, Cundinamarca, Colombia
Start Date
July 1, 2020
Primary Completion Date
February 1, 2021
Completion Date
February 1, 2021
Last Updated
June 11, 2020
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Fundación Santa Fe de Bogota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions